imipenem, anhydrous has been researched along with Necrotizing Pyelonephritis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akers, W; Brown, ML; Du, J; Kartsonis, NA; Lee, YC; Mariyanovski, V; McLeroth, P; Paschke, A; Pedley, A; Sims, M | 1 |
| Chau, F; Dion, S; Fantin, B; Lefort, A; Lepeule, R; Massias, L; Rossi, B; Soubirou, JF | 1 |
| Duttaroy, DD; González Patzán, LD; Kreidly, Z; Lipka, J; Sable, C; Stricklin, D; Vazquez, JA | 1 |
| Baba, S; Furuhata, M; Inoue, M; Iwamura, M | 1 |
| Freedman, LR; Guze, LB; Guze, PA; Ishida, K; Kalmanson, GM | 1 |
| Hertle, L; Ludwig, K; Pühse, G; Roos, N | 1 |
| Abe, K; Oishi, Y; Ueda, M; Wada, T | 1 |
| Naber, KG; Salmen, HC; Savov, O | 1 |
| Kletchko, S; Nagappan, R | 1 |
| Matsuda, S; Oh, K; Suzuki, M | 1 |
3 trial(s) available for imipenem, anhydrous and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Pyelonephritis; Urinary Tract Infections; Young Adult | 2017 |
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Cilastatin; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Protease Inhibitors; Pyelonephritis; Urinary Tract Infections | 2012 |
Piperacillin 2 g/tazobactam 0.5 g is as effective as imipenem 0.5 g/cilastatin 0.5 g for the treatment of acute uncomplicated pyelonephritis and complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Pyelonephritis; Sample Size; Tazobactam; Thienamycins; Urinary Tract Infections | 2002 |
7 other study(ies) available for imipenem, anhydrous and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Gene Expression; Humans; Imipenem; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Plasmids; Pyelonephritis; Urinary Tract Infections; Uropathogenic Escherichia coli | 2016 |
Combined effect of clarithromycin and imipenem/cilastatin against urinary biofilm infection after pyeloplasty.
Topics: Adult; Biofilms; Cilastatin; Clarithromycin; Drug Therapy, Combination; Humans; Imipenem; Kidney Calculi; Kidney Pelvis; Male; Postoperative Complications; Pseudomonas aeruginosa; Pseudomonas Infections; Pyelonephritis; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Ureteral Obstruction | 2003 |
Treatment of staphylococcal pyelonephritis in rats with N-formimidoyl thienamycin.
Topics: Animals; Cilastatin; Cyclopropanes; Dipeptidases; Imipenem; Male; Methicillin; Pyelonephritis; Rats; Rats, Inbred Strains; Staphylococcal Infections; Thienamycins | 1984 |
[Intra- and peri-renal gas formation. Bilateral emphysematous pyelonephritis].
Topics: Aged; Combined Modality Therapy; Fatal Outcome; Female; Humans; Imipenem; Kidney; Lumbar Vertebrae; Metronidazole; Nephrectomy; Postoperative Complications; Pyelonephritis; Reoperation; Spinal Stenosis; Tomography, X-Ray Computed | 1999 |
[A case of effective endotoxin adsorption therapy for septic shock due to acute pyelonephritis].
Topics: Acute Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxins; Escherichia coli; Escherichia coli Infections; Hemofiltration; Humans; Imipenem; Male; Middle Aged; Pyelonephritis; Shock, Septic; Sorption Detoxification; Treatment Outcome; Ureteral Calculi | 2000 |
Bilateral emphysematous pyelonephritis resolving to medical therapy.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Emphysema; Escherichia coli Infections; Female; Humans; Imipenem; Middle Aged; Pyelonephritis; Tomography, X-Ray Computed | 1992 |
[Clinical studies on imipenem/cilastatin sodium in the perinatal period].
Topics: Adult; Bacterial Infections; Cilastatin; Drug Evaluation; Drug Therapy, Combination; Endometritis; Female; Humans; Imipenem; Infusions, Intravenous; Pregnancy; Pregnancy Complications, Infectious; Puerperal Infection; Pyelonephritis | 1988 |